against CD28 or CD152

Industry

CPC
C07K16/2818

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07KPEPTIDES C07K16/00Immunoglobulins [IGs]

Current Industry

C07K16/2818against CD28 or CD152

Industries

Patents Grantslast 30 patents

Information Patent Grant
Human Kynureninase enzymes and uses thereof
- Patent number 12,144,828
- Issue date Nov 19, 2024
- Board of Regents, The University of Texas System
- George Georgiou
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 12,145,927
- Issue date Nov 19, 2024
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for decreasing soluble immune receptor CD28
- Patent number 12,139,534
- Issue date Nov 12, 2024
- BIOND BIOLOGICS LTD.
- Motti Hakim
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EphA3 directed CAR-T cells for treatment of tumors
- Patent number 12,139,544
- Issue date Nov 12, 2024
- Mayo Foundation for Medical Education and Research
- Cameron Durrant
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modified chimeric receptors and related compositions and methods
- Patent number 12,139,526
- Issue date Nov 12, 2024
- Juno Therapeutics, Inc.
- Lucas James Thompson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for upregulating immune responses using combinations of ant...
- Patent number 12,139,535
- Issue date Nov 12, 2024
- Dana-Farber Cancer Institute, Inc.
- Gordon J. Freeman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
5-thiazolecarboxamide kinase inhibitor and uses thereof
- Patent number 12,139,480
- Issue date Nov 12, 2024
- iOmx Therapeutics AG
- Peter Sennhenn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Agonistic anti TNFR2 antibody molecules
- Patent number 12,139,547
- Issue date Nov 12, 2024
- BioInvent International AB
- Björn Frendéus
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Halogenated xanthene composition and method for treating hematologi...
- Patent number 12,133,840
- Issue date Nov 5, 2024
- Provectus Pharmatech, Inc.
- Eric A. Wachter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mutant anti-CTLA-4 antibodies with improved immunotherapeutic effec...
- Patent number 12,129,299
- Issue date Oct 29, 2024
- ONCOC4, INC.
- Yang Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods, kits, agents and apparatuses for transduction
- Patent number 12,129,477
- Issue date Oct 29, 2024
- Juno Therapeutics GmbH
- Keenan Bashour
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Combination of a selective histone deacetylase 3 (HDAC3) inhibitor...
- Patent number 12,128,018
- Issue date Oct 29, 2024
- KDAc Therapeutics, Inc.
- Edward Holson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for the treatment of cancer characterized...
- Patent number 12,129,284
- Issue date Oct 29, 2024
- Duke University
- Chuan-Yuan Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapies of HDAC inhibitors and PD-1 inhibitors
- Patent number 12,122,833
- Issue date Oct 22, 2024
- HUYABIO International, LLC
- Reid P. Bissonnette
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-PD-1 antibodies
- Patent number 12,122,834
- Issue date Oct 22, 2024
- Merck Sharp & Dohme LLC
- Laurence Fayadat-Dilman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoform-selective TGFB1 inhibitors and use thereof
- Patent number 12,122,823
- Issue date Oct 22, 2024
- SCHOLAR ROCK, INC.
- Abhishek Datta
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Induction and enhancement of antitumor immunity involving virus vec...
- Patent number 12,116,412
- Issue date Oct 15, 2024
- New York University
- Daniel Meruelo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for treating inflammation and cancer
- Patent number 12,109,249
- Issue date Oct 8, 2024
- University of Louisville Research Foundation
- Nejat Egilmez
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD73 compounds
- Patent number 12,110,294
- Issue date Oct 8, 2024
- Gilead Sciences, Inc.
- Mark J. Bartlett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-BTLA antibody
- Patent number 12,110,329
- Issue date Oct 8, 2024
- SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
- Hai Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions of programmed death receptor 1 (PD-1) antibodies and m...
- Patent number 12,110,330
- Issue date Oct 8, 2024
- Merck Sharp & Dohme LLC
- Mark A. Brower
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modulating gabarap to modulate immunogenic cell death
- Patent number 12,109,266
- Issue date Oct 8, 2024
- Dana-Farber Cancer Institute, Inc.
- Kenneth C. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Canine monoclonal antibodies against canine cytotoxic T lymphocyte...
- Patent number 12,110,331
- Issue date Oct 8, 2024
- The Trustees of the University of Pennsylvania
- Nicola J. Mason
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-ILT3 antibodies and antibody drug conjugates
- Patent number 12,110,326
- Issue date Oct 8, 2024
- Bluefin BioMedicine, Inc.
- Jaime Rene Darce
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-TIGIT antibodies
- Patent number 12,102,680
- Issue date Oct 1, 2024
- Merck Sharp & Dohme LLC
- Sybil M. G. Williams
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-LAG3 antibodies and antigen-binding fragments
- Patent number 12,102,681
- Issue date Oct 1, 2024
- Merck Sharp & Dohme LLC
- Linda Liang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and materials for treating cancer
- Patent number 12,103,978
- Issue date Oct 1, 2024
- Shanghai Miracogen Inc.
- Chaohong Hu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Non-cytotoxic modified cells and use thereof
- Patent number 12,098,202
- Issue date Sep 24, 2024
- The National Institute for Biotechnology in the Negev Ltd.
- Alon Monsonego
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for promoting and potentiating T-cell medi...
- Patent number 12,098,212
- Issue date Sep 24, 2024
- Purinomia Biotech, Inc.
- Yan Wu Shang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sequential treatment of cancers using 6-thio-dG, checkpoint inhibit...
- Patent number 12,097,213
- Issue date Sep 24, 2024
- The Board of Regents of the University of Texas System
- Jerry Shay
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER
- Publication number 20240382572
- Publication date Nov 21, 2024
- COGNATE BIOSERVICES, INC.
- Marnix Leo Bosch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Composition Comprising HDAC Inhibitor and Immune Checkpoin Inhibito...
- Publication number 20240382463
- Publication date Nov 21, 2024
- Avstera Therapeutics Corp.
- Karthik Musunuri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING CALCITONIN GENE-RELATED PEPTIDE (CGRP) - EXPRE...
- Publication number 20240383973
- Publication date Nov 21, 2024
- THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA
- Maureen Cox
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOMODULATING TREATMENTS OF BODY CAVITIES
- Publication number 20240382420
- Publication date Nov 21, 2024
- UROGEN PHARMA LTD
- Caretha L. Creasy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY WITH DEUTERATED IMIDAZOQUINOLINES
- Publication number 20240382469
- Publication date Nov 21, 2024
- BIRDIE BIOPHARMACEUTICALS, INC.
- Pei-Jou LEE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-OX40 ANTIBODIES, MULTISPECIFIC ANTIBODIES AND METHODS OF USE
- Publication number 20240383996
- Publication date Nov 21, 2024
- SHANGHAI HENLIUS BIOTECH, INC.
- Wenfeng XU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NKp46-Targeted Modified IL-2 Polypeptides and Uses Thereof
- Publication number 20240376198
- Publication date Nov 14, 2024
- Inhibrx, Inc.
- John C. Timmer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTRACELLULAR DELIVERY OF BIOMOLECULES TO MODIFY IMMUNE RESPONSE
- Publication number 20240374654
- Publication date Nov 14, 2024
- StemCell Technologies Canada Inc.
- Scott LOUGHHEAD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PD-1 IMMUNOGLOBULIN POLYPEPTIDES AND USES THEREOF
- Publication number 20240376203
- Publication date Nov 14, 2024
- Trustees of Tufts College
- Peter A. Bullock
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEIN SPECIFICALLY BINDING TO PD-1 AND PHARMACEUTICAL USE THEREOF
- Publication number 20240376204
- Publication date Nov 14, 2024
- JIANGSU HENGRUI PHARMACEUTICALS CO., LTD.
- Zhiliang CAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING LATE STAGE LUNG CANCER
- Publication number 20240376206
- Publication date Nov 14, 2024
- AstraZeneca AB
- HAIYI JIANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION RADIOTHERAPY
- Publication number 20240374764
- Publication date Nov 14, 2024
- Telix Pharmaceuticals (Innovations) Pty Ltd.
- Michael Paul Wheatcroft
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEASE-ACTIVATED POLYPEPTIDES
- Publication number 20240376171
- Publication date Nov 14, 2024
- HOFFMANN-LA ROCHE INC.
- Samuele CALABRO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SINGLE-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF
- Publication number 20240376187
- Publication date Nov 14, 2024
- HCW Biologics, Inc.
- Hing Wong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MULTISPECIFIC ANTIBODIES FOR USE IN TREATING DISEASES
- Publication number 20240376213
- Publication date Nov 14, 2024
- Yeda Research and Development Co. Ltd.
- Ido AMIT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS
- Publication number 20240376218
- Publication date Nov 14, 2024
- Bayer Aktiengesellschaft
- Sandra Berndt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATIONS OF IMMUNE CHECK POINT INHIBITORS OR LIKE
- Publication number 20240366757
- Publication date Nov 7, 2024
- Dr. Reddy's Laboratories Limited
- Murali JAYARAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTI-FLT3/CD3 ANTIBODIES AND METHODS OF USE
- Publication number 20240368288
- Publication date Nov 7, 2024
- Hemogenyx Pharmaceuticals LLC
- Vladislav M. SANDLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS FOR ENHANCING IMMUNOTHERAPY EFFICACY IN COLORECTAL CAN...
- Publication number 20240366693
- Publication date Nov 7, 2024
- The Chinese University of Hong Kong
- Jun Yu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A METHOD OF IMPROVING STABILITY OF IMMUNE CHECK POINT INHIBITORS
- Publication number 20240368284
- Publication date Nov 7, 2024
- Dr. Reddy's Laboratories Limited
- Murali JAYARAMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING EPCAM
- Publication number 20240368309
- Publication date Nov 7, 2024
- HOFFMANN-LA ROCHE INC.
- Stephan GASSER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-NECTIN4 ANTIBODIES AND MULTI-SPECIFIC PROTEIN COMPLEXES COMPRI...
- Publication number 20240368275
- Publication date Nov 7, 2024
- Elpis Biopharmaceuticals
- Kehao Zhao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20240368245
- Publication date Nov 7, 2024
- Cue Biopharma, Inc.
- Ronald D. Seidel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CANCER TREATMENT COMBINATIONS
- Publication number 20240366597
- Publication date Nov 7, 2024
- Viracta Subsidiary, Inc.
- Lisa ROJKJAER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CECAM6 ANTIBODIES WITH REDUCED SIDE-EFFECTS
- Publication number 20240368280
- Publication date Nov 7, 2024
- Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
- Mark Trautwein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MOLECULES FOR MODULATING THE IMMUNE SYSTEM AND USES THEREOF
- Publication number 20240368283
- Publication date Nov 7, 2024
- Seismic Therapeutic, Inc.
- Nathan Higginson-Scott
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Primary T-Cell Expansion
- Publication number 20240358760
- Publication date Oct 31, 2024
- NantBio, Inc.
- Krsto Sbutega
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Therapeutic Anti-CD9 Antibody
- Publication number 20240360239
- Publication date Oct 31, 2024
- KLING BIOTHERAPEUTICS B.V.
- Hergen SPITS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NANOPARTICLES FOR CANCER TREATMENT
- Publication number 20240358639
- Publication date Oct 31, 2024
- Ilya Rachman
- B82 - NANO-TECHNOLOGY
Information Patent Application
LILRB1 and LILRB2 ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20240360214
- Publication date Oct 31, 2024
- Pfizer Inc.
- James Reasoner APGAR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

against CD28 or CD152

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Human Kynureninase enzymes and uses thereof

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Methods and compositions for decreasing soluble immune receptor CD28

EphA3 directed CAR-T cells for treatment of tumors

Modified chimeric receptors and related compositions and methods

Methods for upregulating immune responses using combinations of ant...

5-thiazolecarboxamide kinase inhibitor and uses thereof

Agonistic anti TNFR2 antibody molecules

Halogenated xanthene composition and method for treating hematologi...

Mutant anti-CTLA-4 antibodies with improved immunotherapeutic effec...

Methods, kits, agents and apparatuses for transduction

Combination of a selective histone deacetylase 3 (HDAC3) inhibitor...

Compositions and methods for the treatment of cancer characterized...

Combination therapies of HDAC inhibitors and PD-1 inhibitors

Anti-PD-1 antibodies

Isoform-selective TGFB1 inhibitors and use thereof

Induction and enhancement of antitumor immunity involving virus vec...

Compositions and methods for treating inflammation and cancer

CD73 compounds

Anti-BTLA antibody

Compositions of programmed death receptor 1 (PD-1) antibodies and m...

Modulating gabarap to modulate immunogenic cell death

Canine monoclonal antibodies against canine cytotoxic T lymphocyte...

Anti-ILT3 antibodies and antibody drug conjugates

Anti-TIGIT antibodies

Anti-LAG3 antibodies and antigen-binding fragments

Methods and materials for treating cancer

Non-cytotoxic modified cells and use thereof

Methods and compositions for promoting and potentiating T-cell medi...

Sequential treatment of cancers using 6-thio-dG, checkpoint inhibit...

Patents Applicationslast 30 patents

COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER

Composition Comprising HDAC Inhibitor and Immune Checkpoin Inhibito...

METHODS FOR TREATING CALCITONIN GENE-RELATED PEPTIDE (CGRP) - EXPRE...

IMMUNOMODULATING TREATMENTS OF BODY CAVITIES

COMBINATION THERAPY WITH DEUTERATED IMIDAZOQUINOLINES

ANTI-OX40 ANTIBODIES, MULTISPECIFIC ANTIBODIES AND METHODS OF USE

NKp46-Targeted Modified IL-2 Polypeptides and Uses Thereof

INTRACELLULAR DELIVERY OF BIOMOLECULES TO MODIFY IMMUNE RESPONSE

ANTI-PD-1 IMMUNOGLOBULIN POLYPEPTIDES AND USES THEREOF

PROTEIN SPECIFICALLY BINDING TO PD-1 AND PHARMACEUTICAL USE THEREOF

COMPOSITIONS AND METHODS FOR TREATING LATE STAGE LUNG CANCER

COMBINATION RADIOTHERAPY

PROTEASE-ACTIVATED POLYPEPTIDES

SINGLE-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF

MULTISPECIFIC ANTIBODIES FOR USE IN TREATING DISEASES

CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS

FORMULATIONS OF IMMUNE CHECK POINT INHIBITORS OR LIKE

BISPECIFIC ANTI-FLT3/CD3 ANTIBODIES AND METHODS OF USE

COMPOSITIONS FOR ENHANCING IMMUNOTHERAPY EFFICACY IN COLORECTAL CAN...

A METHOD OF IMPROVING STABILITY OF IMMUNE CHECK POINT INHIBITORS

AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING EPCAM

ANTI-NECTIN4 ANTIBODIES AND MULTI-SPECIFIC PROTEIN COMPLEXES COMPRI...

MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF

CANCER TREATMENT COMBINATIONS

ANTI-CECAM6 ANTIBODIES WITH REDUCED SIDE-EFFECTS

MOLECULES FOR MODULATING THE IMMUNE SYSTEM AND USES THEREOF

Primary T-Cell Expansion

Therapeutic Anti-CD9 Antibody

NANOPARTICLES FOR CANCER TREATMENT

LILRB1 and LILRB2 ANTIBODIES AND METHODS OF USE THEREOF